Show simple item record

dc.contributor.authorSykes, Andrew J
dc.contributor.authorLogue, John P
dc.contributor.authorSlevin, Nicholas J
dc.contributor.authorGupta, Nirmal K
dc.date.accessioned2010-01-25T09:51:51Z
dc.date.available2010-01-25T09:51:51Z
dc.date.issued1995
dc.identifier.citationAn analysis of radiotherapy in the management of 104 patients with parotid carcinoma. 1995, 7 (1):16-20 Clin Oncolen
dc.identifier.issn0936-6555
dc.identifier.pmid7727300
dc.identifier.urihttp://hdl.handle.net/10541/90538
dc.description.abstractA retrospective analysis was made of 104 patients with parotid carcinoma treated with radical radiotherapy between 1977 and 1986. Eighty-seven patients received postoperative radiotherapy and 17 had radiotherapy alone. The 5- and 10-year survival figures, corrected for intercurrent deaths, were 60% and 49% respectively, with primary control rates of 68% and 58%. Local control was significantly better for patients initially presenting with T1/T2 disease, but local relapse still occurred in 23% of these patients. Of 13 patients with acinic cell tumours, four developed local recurrence and a further two had metastatic disease. These patterns of relapse suggest that patients with parotid carcinoma should receive postoperative radiotherapy irrespective of disease stage or histological type.
dc.language.isoenen
dc.subjectCancer Recurrenceen
dc.subjectParotid Canceren
dc.subject.meshAdolescent
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshCombined Modality Therapy
dc.subject.meshFemale
dc.subject.meshFollow-Up Studies
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshNeoplasm Recurrence, Local
dc.subject.meshParotid Neoplasms
dc.subject.meshPostoperative Period
dc.subject.meshPrognosis
dc.subject.meshRetrospective Studies
dc.subject.meshSurvival Rate
dc.titleAn analysis of radiotherapy in the management of 104 patients with parotid carcinoma.en
dc.typeArticleen
dc.contributor.departmentChristie Hospital, Manchester, UK.en
dc.identifier.journalClinical Oncologyen
html.description.abstractA retrospective analysis was made of 104 patients with parotid carcinoma treated with radical radiotherapy between 1977 and 1986. Eighty-seven patients received postoperative radiotherapy and 17 had radiotherapy alone. The 5- and 10-year survival figures, corrected for intercurrent deaths, were 60% and 49% respectively, with primary control rates of 68% and 58%. Local control was significantly better for patients initially presenting with T1/T2 disease, but local relapse still occurred in 23% of these patients. Of 13 patients with acinic cell tumours, four developed local recurrence and a further two had metastatic disease. These patterns of relapse suggest that patients with parotid carcinoma should receive postoperative radiotherapy irrespective of disease stage or histological type.


This item appears in the following Collection(s)

Show simple item record